Endocrine

DC 7914

Neoplasm, malignant, any specified part of the endocrine system

Educational use only. Not legal or medical advice. Read 38 CFR §4.119 on eCFR
Diagnostic Code
7914
CFR Section
§4.119 — Endocrine

Rating Tiers

100%

Note: A rating of 100 percent shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local recurrence or metastasis, rate on residuals.

What Raters Look For

Based on M21-1 adjudication criteria for Endocrine conditions. These are the factors a VA rater evaluates when assigning a rating percentage.

M21-1 III.iv.4.I
  • •Lab values: HbA1c and fasting glucose for diabetes; TSH/T4 for thyroid conditions
  • •Medication requirements: whether insulin is required vs. oral agents only
  • •Regulation of the condition: whether it is well-controlled or labile
  • •Complications present: neuropathy, retinopathy, nephropathy, vascular disease
  • •Frequency of hypoglycemic episodes and whether they require medical assistance
  • •Dietary restrictions required for management
NoteFor diabetes (DC 7913), insulin use alone qualifies for 20%. Raters look for regulation issues and complications to determine higher ratings.